Drug name - Troxyca Er

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8685443 PFIZER Sequestering subunit and related compositions and methods Jul, 2025

(2 years from now)

US7815934 PFIZER Sequestering subunit and related compositions and methods Dec, 2027

(5 years from now)

Drugs and Companies using NALTREXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE ingredient

Treatment: Management of pain severe enough to require daily, around-the-clock, long term opioid treatment by orally administering a plurality of composite subunits as claimed

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
1.2MG;10MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued
2.4MG;20MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued
3.6MG;30MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued
4.8MG;40MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued
7.2MG;60MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued
9.6MG;80MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.